"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

NCT07488351 | Recruiting

• 1 other identifier: 2026-03-130
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.

Conditions

Parkinson Disease; Physical Disability

Outcome Measures

Primary Outcomes (3)

• Self-Compassion Scale (SCS) Total Score

  Self-Compassion Scale (SCS) total score. The Self-Compassion Scale consists of 26 items scored on a 1- to 5-point Likert scale. Total scores range from 1 to 5 (calculated as the mean of all items), with higher scores indicating greater self-compassion (better outcome).

  Baseline (at the time of questionnaire completion)

• Self-Efficacy for Managing Chronic Disease 6-Item Scale Total Score

  Self-Efficacy for Managing Chronic Disease 6-Item Scale total score. The scale consists of 6 items scored from 1 (not at all confident) to 10 (totally confident). The total score is calculated as the mean of the six items, ranging from 1 to 10, with higher scores indicating greater self-efficacy for managing chronic disease (better outcome).

  Baseline (at the time of questionnaire completion)

• Unified Parkinson's Disease Rating Scale (UPDRS) Total Score

  Unified Parkinson's Disease Rating Scale (UPDRS) total score. The total score ranges from 0 to 199, with higher scores indicating greater Parkinson's disease severity and worse clinical status (worse outcome).

  Baseline (at the time of questionnaire completion)

Secondary Outcomes (4)

• Timed Up and Go (TUG) Test Completion Time in Seconds

  Baseline (at the time of questionnaire completion)

• Six-Minute Walk Test (6MWT) Distance in Meters

  Baseline (at the time of questionnaire completion)

• Mini-Balance Evaluation Systems Test (Mini-BESTest) Total Score

  Baseline (at the time of questionnaire completion)

• Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score

  Baseline (at the time of questionnaire completion)

Interventions

Self-Report Questionnaire Assessment OTHER

This study does not involve any therapeutic intervention. Participants will complete a set of self-report questionnaires assessing self-compassion, self-efficacy, symptom severity, functional status, and quality of life. Data will be collected in a single session for observational analysis.

Eligibility Criteria

• Age: 40 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population will consist of individuals diagnosed with Parkinson's disease who are classified as Hoehn and Yahr stage 1-3, aged between 40 and 85 years, and have sufficient cognitive function (MMSE ≥ 24). Participants will be recruited from patients attending the Movement Disorders Outpatient Clinic of the Neurology Department

You may qualify if:

• Clinical diagnosis of Parkinson's disease
• Hoehn and Yahr stage 1-3
• Age 40 to 85 years
• Mini-Mental State Examination (MMSE) score ≥24
• Sufficient cognitive function to communicate and complete study assessments
• Attending the Movement Disorders Outpatient Clinic, Department of Neurology
• Able and willing to provide written informed consent

You may not qualify if:

• Major depressive disorder or psychotic disorder
• Advanced dementia
• Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
• Severe cardiovascular or respiratory disease
• Additional neurological or orthopedic conditions that may affect assessment performance
• Severe visual or hearing impairment that could interfere with study assessments
• Inability to cooperate with the physiotherapist during study assessments

Sponsors & Collaborators

• Acibadem University: lead

Study Sites (1)

Acibadem University

Istanbul, Turkey, +90, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases

Central Study Contacts

Nuray ALACA

CONTACT

05324251290; nuray.alaca@acibadem.edu.tr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc. Prof. Nuray Alaca

Study Record Dates

• First Submitted: March 18, 2026
• First Posted: March 23, 2026
• Study Start: March 30, 2026
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): March 30, 2027
• Last Updated: July 15, 2026

Record last verified: 2026-07

Locations

TU (1)